Asia-Pacific Balloon Catheter Market Segmentation, By Type (PTCA Balloon Catheters, CTO Balloon Catheters, and Microcatheters), Product Type (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Stent Graft Balloon Catheter, and Scoring Balloon Catheter), Delivery Platform (Rapid Exchange (RX) / Monorail Balloon Catheter, Over-The-Wire (OTW), and Fixed Wire (FW) Balloon Catheter), Compliance (Non-Compliant, Semi-Compliant, and Compliant), Balloon Material (Nylon, Polyethylene Terephthalate (PET), Polyethylene (PE), Silicone, Polyolefin Copolymer, and Others), Balloon Type (High-Pressure Balloons and Elastomeric Balloons), Application (Coronary Artery Disease, Peripheral Artery Disease, and Others), End User (Hospitals, Specialty Centers, Ambulatory Surgery Centers, and Others), Distribution Channel (Direct Tender, Third Party Distribution, and Others) - Industry Trends and Forecast to 2031.
Asia-Pacific Balloon Catheter Market Analysis and Insights
According to an article published by BMC, in February 2024, as per the 10-year cohort study in Iran, a total of 225 cardiovascular events were reported over a follow-up period of 15,420.11 person-years. Of these events, 135 occurred in men and 90 in women. The 10-year cumulative incidence rate was 16.8 (14.4–19.2) per 1000 person-years for males and 12.0 (9.5–14.5) per 1000 person-years for females. This data reflects a rising prevalence of cardiovascular diseases, with significant incidence rates in both men and women. The increasing number of cardiovascular events underscores the growing need for effective treatments, driving up demand for advanced medical devices such as balloon catheters.
Data Bridge Market Research analyzes that the Asia-Pacific balloon catheter market is expected to reach USD 1448.31 million by 2031 from USD 835.06 million in 2023, growing with a CAGR of 7.2% in the forecast period of 2024 to 2031.
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016–2021)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
Type (PTCA Balloon Catheters, CTO Balloon Catheters, and Microcatheters), Product Type (Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Stent Graft Balloon Catheter, and Scoring Balloon Catheter), Delivery Platform (Rapid Exchange (RX) / Monorail Balloon Catheter, Over-The-Wire (OTW), and Fixed Wire (FW) Balloon Catheter), Compliance (Non-Compliant, Semi-Compliant, and Compliant), Balloon Material (Nylon, Polyethylene Terephthalate (PET), Polyethylene (PE), Silicone, Polyolefin Copolymer, and Others), Balloon Type (High-Pressure Balloons and Elastomeric Balloons), Application (Coronary Artery Disease, Peripheral Artery Disease, and Others), EndUser (Hospitals, Specialty Centers, Ambulatory Surgery Centers, and Others), Distribution Channel (Direct Tender, Third Party Distribution, and Others)
|
|
Countries Covered
|
Japan, China, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Philippines, and Rest of Asia-Pacific
|
|
Market Players Covered
|
Boston Scientific Corporation (U.S.), Medtronic (U.S.), Abbott (U.S.), Terumo Corporation (Japan), BD (U.S.), B. Braun SE (Germany), Koninklijke Philips N.V. (Netherlands), Teleflex Incorporated (U.S.), Cook (U.S.), Lepu Medical Technology (Beijing) Co., Ltd. (China), KANEKA CORPORATION (Japan), MicroPort Scientific Corporation (China), Acrostak Int. Distr. Sàrl (Switzerland), Biotronik (Germany), Alvimedica (Turkey), SMT (India), BALTON (Poland), APR Medtech Ltd (England), Advin Health Care (India) among others
|
Market Definition
A balloon catheter is a flexible, tubular medical device with an inflatable balloon at its tip, designed for insertion into blood vessels or other body cavities. It is commonly used in minimally invasive procedures to dilate narrowed or blocked vessels (as in angioplasty), deliver drugs, or perform diagnostic tests. The balloon can be inflated and deflated to open up blockages or position medical devices precisely within the body. Balloon catheters are frequently utilized in cardiovascular, urological, and gastrointestinal treatments.
Asia-Pacific Balloon Catheter Market Dynamics
This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail below:
Driver
- Rising Prevalence of Cardiovascular Diseases (CVDs)
The rising prevalence of cardiovascular diseases (CVDs), including conditions like coronary artery disease (CAD) and Peripheral Artery Disease (PAD), is significantly propelling the demand for balloon catheters, particularly in angioplasty procedures. CVDs have become a leading cause of death, with lifestyle changes such as increased consumption of high-fat diets, smoking, physical inactivity, and stress contributing to their growing incidence. As populations continue to age and life expectancy rises, the prevalence of these diseases is expected to surge, creating a growing need for effective treatment methods.
Balloon catheters, which are widely used in angioplasty, play a crucial role in opening up blocked or narrowed arteries, allowing improved blood flow to the heart and other vital organs. In procedures like percutaneous coronary intervention (PCI), balloon catheters are used to dilate the coronary arteries, reducing the risk of heart attacks and other complications associated with coronary artery blockages. Similarly, in the case of PAD, which affects blood flow to the limbs, balloon catheters help restore circulation, preventing limb loss and enhancing patient outcomes.
Opportunity
- Technological Advancements in Balloon Catheter Technology
Technological advancements in balloon catheter technology offer substantial opportunities for growth in the Asia-Pacific balloon catheter market. One significant development is the emergence of bioabsorbable balloon catheters made from materials like Polylactic Acid (PLA). These innovative devices provide temporary support during angioplasty and dissolve naturally in the body after the procedure. This feature minimizes long-term complications and promotes faster vascular healing, which could enhance patient outcomes and broaden the market for balloon catheters.
In addition, the advancement of drug-coated balloon technologies, including those with nitric oxide and sirolimus coatings, represents a promising area of development. These coatings aim to reduce the risks of restenosis and thrombosis more effectively than traditional methods. Ongoing research supports their clinical efficacy, particularly in complex cardiovascular interventions, which could drive increased adoption and expand their use.
Moreover, the market is also advancing into specialized applications with techniques such as balloon valvuloplasty and balloon atrial septostomy. Balloon valvuloplasty addresses stenotic heart valves, while balloon atrial septostomy is used for congenital heart defects. These procedures demand high-precision balloon catheter devices designed for both pediatric and adult patients, offering new opportunities and increasing the market potential for advanced catheter technologies.
Restraint
- High Cost of Balloon Catheters
The high cost of balloon catheter-based procedures, particularly those utilizing drug-eluting and cutting balloon catheters, presents a major issue to the growth of the Asia-Pacific balloon catheter market. Despite offering better outcomes, such as lower rates of artery re-narrowing and enhanced treatment precision, these advanced devices are often too expensive, especially in low- and middle-income regions. The overall cost, including the catheters, hospital stays, diagnostic tests, and post-procedure care, can make these treatments unaffordable for many patients in these areas.
This financial burden limits the adoption of balloon catheter procedures in emerging markets, where healthcare budgets are tight, and patients often lack insurance or financial support. Additionally, healthcare providers in such regions may refrain from investing in costly medical devices due to budget constraints, opting for cheaper alternatives or traditional surgical methods instead. The lack of advanced balloon catheter technologies in low-resource settings, combined with insufficient infrastructure to support these procedures, further restricts market growth in these regions due to the high associated costs.
Recent Developments
- In November 2023, Boston Scientific concluded its acquisition of Relevant Medsystems, adding the Intracept Intraosseous Nerve Ablation System to its chronic pain portfolio. The acquisition, costing USD 850 million upfront plus contingent payments, expands access to vertebrogenic pain treatment through national coverage, benefiting over 150 million lives
- In April 2023, Abbott completed its acquisition of Cardiovascular Systems, Inc., a company known for its innovative atherectomy system used in treating vascular disease. CSI's system, which prepares vessels for angioplasty or stenting, became part of Abbott’s vascular portfolio. CSI shares ceased trading on Nasdaq that day
- In August 2022, Boston Scientific announced the acquisition of Obsidio, Inc., a company behind the GEM technology for embolization in peripheral vasculature. The semi-solid GEM material, recently FDA-cleared, simplifies embolization procedures with its unique gel-like properties. The transaction was not expected to affect Boston Scientific's 2022 earnings materially
- In February 2022, Medtronic received FDA approval for its Freezor and Freezor Xtra catheters to treat pediatric atrioventricular nodal reentrant tachycardia (AVRNT). This cryoablation therapy, is effective for over 140,000 patients worldwide, targets abnormal heart rhythms in children, helping to prevent life-threatening complications and support normal heart function
Asia-Pacific Balloon Catheter Market Scope
The Asia-Pacific balloon catheter market is segmented into nine notable segments based on type, product type, delivery platform, compliance, balloon material, balloon type, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Type
- PTCA Balloon Catheters
- CTO Balloon Catheters
- Microcatheters
On the basis of type, the market is segmented into PTCA balloon catheters, CTO balloon catheters, and microcatheters.
Product Type
- Normal Balloon Catheter
- Drug Eluting Balloon Catheter
- Cutting Balloon Catheter
- Stent Graft Balloon Catheter
- Scoring Balloon Catheter
On the basis of product type, the market is segmented into normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, stent graft balloon catheter, and scoring balloon catheter.
Delivery Platform
- Rapid Exchange (RX) / Monorail Balloon Catheter
- Over-The-Wire (OTW)
- Fixed Wire (FW) Balloon Catheter
On the basis of delivery platform, the market is segmented into rapid exchange (RX) / monorail balloon catheter, over-the-wire (OTW), and fixed wire (FW) balloon catheter.
Compliance
- Non-Compliant
- Semi-Compliant
- Compliant
On the basis of compliance, the market is segmented into non-compliant, semi-compliant and compliant.
Balloon Material
- Nylon
- Polyethylene Terephthalate (PET)
- Polyethylene (PE)
- Silicone
- Polyolefin Copolymer
- Others
On the basis of balloon material, the market is segmented into nylon, polyethylene terephthalate (PET), polyethylene (PE), silicone, polyolefin copolymer, and others.
Balloon Type
- High-Pressure Balloons
- Elastomeric Balloons
On the basis of balloon type, the market is segmented into high-pressure balloons, and elastomeric balloons.
Application
- Coronary Artery Disease
- Peripheral Artery Disease
- Others
On the basis of application, the market is segmented into coronary artery disease, peripheral artery disease, and others.
End User
- Hospitals
- Specialty Centers
- Ambulatory Surgery Centers
- Others
On the basis of end user, the market is segmented into hospitals, specialty centers, ambulatory surgery centers, and others.
Distribution Channel
- Direct Tender
- Third Party Distribution
- Others
On the basis of distribution channel, the market is segmented into direct tender, third party distribution, and others.
Asia-Pacific Balloon Catheter Market Regional Analysis/Insights
The Asia-Pacific balloon catheter market is segmented into nine notable segments based on type, product type, delivery platform, compliance, balloon material, balloon type, application, end user, and distribution channel.
The countries covered in this market report are Japan, China, India, South Korea, Australia, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Philippines, and rest of Asia-Pacific.
Japan is expected to dominate and fastest growing country in the Asia-Pacific region due to robust initiatives taken by government. The region's increasing number of consumers in the market contribute to a strong demand for balloon catheter.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands and the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Balloon Catheter Market Share Analysis
The Asia-Pacific balloon catheter market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the market.
Some of the major market players are Boston Scientific Corporation (U.S.), Medtronic (U.S.), Abbott (U.S.), Terumo Corporation (Japan), BD (U.S.), B. Braun SE (Germany), Koninklijke Philips N.V. (Netherlands) among others.
SKU-